Bio/Pharma News

May 30, 2018
By Pharmaceutical Technology Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 30, 2018
By Pharmaceutical Technology Editors
Bayer received conditional approval from the Antitrust Division of the United States Department of Justice to acquire Monsanto in a deal worth $66 billion.
May 29, 2018
By Pharmaceutical Technology Editors
The European Commission has approved Zessly (infliximab), a biosimilar to Johnson & Johnson’s blockbuster Remicade (infliximab).
May 25, 2018
By Pharmaceutical Technology Editors
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
May 23, 2018
By Pharmaceutical Technology Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 23, 2018
By Pharmaceutical Technology Editors
Allergan will buy a potential depression treatment from Aptinyx.
May 23, 2018
By Pharmaceutical Technology Editors
The new drug offers rapid and sustained control of patients’ potassium levels.
May 23, 2018
By Pharmaceutical Technology Editors
WuXi Biologics will build a biologics manufacturing facility in Singapore that will use both fed-batch and continuous perfusion-based single-use bioreactors.
May 22, 2018
By Pharmaceutical Technology Editors
The company has leased and purchased facilities in the United States and Europe to expand its cell therapy pipeline.
May 21, 2018
By Pharmaceutical Technology Editors
The acquisition of AurKa Pharma will help strength Eli Lilly’s oncology pipeline.
native1_300x100
lorem ipsum